# OnCo record immunext (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/immunext/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "immunext" ;
  schema:name "ImmuNext"@en ;
  schema:alternateName "ImmuNext Inc"@en ;
  schema:description "ImmuNext is a small US company that makes antibodies to adjust the immune system. In cancer its main work was an antibody against VISTA, a brake on immune cells, which it licensed first to Janssen and later offered to Curis."@en ;
  schema:url <https://onco.cc/companies/immunext/>, <https://www.immunext.com/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.immunext.com/>, <https://www.sec.gov/Archives/edgar/data/1108205/000119312520002601/d863849dex991.htm>, <https://www.inknowvation.com/sbir/story/sanofi-and-immunext-enter-agreement-develop-treatments-autoimmune-diseases?keywords=> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/vista/> ;
  onco:companies <https://onco.cc/companies/curis/> .